Gharieni’s study into two of its touchless spa treatment concept beds looked at their effects on the Autonomic Nervous System, which is responsible for regulating important bodily functions and stimulating fight-or-flight reactions.
Good health and prevention rely on a sense of balance throughout the ANS.
The trial investigated whether Gharieni’s Welnamis (www.gharieni.com/welnamis) and MLX Quartz (www.gharieni.com/psammo-concept-quartz) beds initiate an anti-inflammatory effect in users and help rebalance their ANS.
Researcher and early human development specialist Sergio Pecorelli, MD, PhD, led the study, in collaboration with Alina Hernandez, vice-chair of the Global Wellness Institute’s Mental Wellness Initiative.
Hernandez told Spa Business Gharieni launched the trial to provide scientific evidence to prove its products’ efficacy. She added that these kinds of studies will be crucial for spa and wellness going forward.
She believes this kind of evidence will help spa and wellness businesses stand out from the crowd and benefit the industry by reassuring customers that healing modalities are scientifically-backed, safe and worth their money.
“We immediately saw improvement in the ANS right after treatments. In fact, we saw peak improvement after three to four treatments, with maintenance and sustained improvement over the eight weeks of the study.
“Chronic stress is one of the greatest challenges to health and wellbeing, because it can trigger chronic inflammation which is ultimately the root of nearly all chronic diseases,” she said.
“This study is especially meaningful during a time when value and authenticity are highly important to the end-consumer,” said Hernandez.
To find out more about the research, go to www.spabusiness.com/Gharieniresearch
